Filing search / Olema Pharmaceuticals, Inc. / "Innovation"

Search information

Olema Pharmaceuticals, Inc.

Companies

"Innovation"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

24 results

Newest first Best match first

10-Q

2024 Q2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

administration’s October 2022 executive order, on February 14, 2023, HHS released a report outlining three new models for testing by the CMS Innovation … technological innovation to develop and maintain our proprietary and intellectual property position. We may also seek to protect our proprietary

6 Aug 24

4:15pm

10-Q

2024 Q1

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

, HHS released a report outlining three new models for testing by the CMS Innovation Center which will be evaluated on their ability to lower the cost … technological innovation to develop and maintain our proprietary and intellectual property position. We may also seek to protect our proprietary position

8 May 24

4:15pm

10-K

2023 FY

OLMA Olema Pharmaceuticals, Inc.

Annual report

for testing by the Centers for Medicare & Medicaid Services, or CMS, Innovation Center which will be evaluated on their ability to lower the cost … innovation or which are in the interest of public health in the European Union. Decentralized Procedure marketing authorizations are available for products

11 Mar 24

4:15pm

10-Q

2023 Q3

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

on how the Center for Medicare and Medicaid Innovation can be further leveraged to test new models for lowering drug costs for Medicare and Medicaid … that are important to the development and implementation of our business. We also rely on trade secrets, know-how and continuing technological innovation

7 Nov 23

4:12pm

10-Q

2023 Q2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

released an additional executive order on October 14, 2022, directing HHS to report on how the Center for Medicare and Medicaid Innovation can be further … technological innovation to develop and maintain our proprietary and intellectual property position. We may also seek to protect our proprietary position

8 Aug 23

4:12pm

10-Q

ohm054te sl46

Quarterly report

9 May 23

4:08pm

DEF 14A

lzsfdzmpoa6

Definitive proxy

28 Apr 23

4:05pm

10-Q

3iz00t p4lk

Quarterly report

8 Nov 22

4:45pm

10-Q

ia8ywg

Quarterly report

9 Aug 22

12:00am

10-Q

7kehpyfq

Quarterly report

9 May 22

4:44pm

DEF 14A

vd37tkpghs5gfz

Definitive proxy

28 Apr 22

4:25pm

10-K

4naa5mzp1o vj

Annual report

28 Feb 22

4:56pm

10-Q

twyy7v3g

Quarterly report

10 Nov 21

4:21pm

10-Q

lbl87ztc5jbev

Quarterly report

10 Aug 21

4:18pm

Prospectus supplement with pricing info

IPO registration (amended)

Filing search / Olema Pharmaceuticals, Inc. / "Innovation"

24 results

Top filers

Top filing types

Recent filing years